http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18654c3a4d11216e16f9ced7f14c6e9d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Halmos |
| name | Balazs Halmos |
| given-name | Balazs |
| organization-name | Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. Department of Oncology, Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center, Bronx, NY, USA; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA Albert Einstein College of Medicine, Bronx, New York, USA 1Division of Medical Oncology, Department of Medicine, Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center, Bronx, New York.; 3Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center, New York, New York. Oncology From the Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York. Xuewen Liu, Mark B. Stoopler, Yufeng Shen, Jinli Chen, Mahesh Mansukhani, Sanjay Koul, Balazs Halmos, and Alain C. Borczuk, Columbia University Medical Center; Haiying Cheng, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY; Xuewen Liu, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China; and Yuxia Jia, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 1Division of Hematology/Oncology, Departments of Montefiore Medical Center/Albert Einstein College of Medicine New York New York From the University of Münster, Münster, Germany; Case Western Reserve University, Cleveland, OH; Cancer Science Institute of Singapore, Singapore; and Harvard Stem Cell Institute, Harvard Medical School, Boston, MA. 3Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, and Columbia University Medical Center, New York City, NY 10032, USA. Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA Department of Oncology, Montefiore Medical Center, Bronx, NY 10467, USA Division of Hematology/Oncology, Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY 10032, USA Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center, New York, NY, USA 12Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, Ohio Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Division of Hematology/Oncology, Montefiore Hospital, Bronx, NY 10461, USA. From the Department of Pharmacology, Yale University School of Medicine, New Haven, CT; and the Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA Montefiore Medical Center, White Plains, NY, USA Departments of Medicine, Pathology and Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA Division of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York. 11Ireland Cancer Center, University Hospitals of Cleveland, Case School of Medicine, Cleveland, Ohio From the Departments of Medicine, Pathology, and Biostatistics, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; Department of Pharmacology, Yale University School of Medicine, New Haven, CT; Departments of Medicine and Pathology, University of Colorado Cancer Center, Aurora, CO; and Instituto Clinico Humanitas Istituto di Ricerca e Cura a Carattere Scientifico, Rozzano, Italy. 1Cancer Biology Program, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital- Columbia University Medical Center, New York, NY, USA Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10467, USA. Division of Hematology and Oncology Columbia University Medical Center New York NY 2Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York. Department of Medical Oncology, Montefiore Medical Center, Montefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.; Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York. Department of Oncology, Montefiore/Albert Einstein Cancer Center, Bronx, NY 10461, USA 1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York. Department of Medical Oncology Montefiore Medical Center, Albert Einstein College of Medicine a , Bronx, New York, USA 1Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston; Montefiore Einstein Center for Cancer Care New York New York Authors' Affiliations: 1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic; 2Division of Hematology/Oncology, Department of Medicine, 3Department of Pathology, and 4Department of Biostatistics, 5Cleveland Clinic Lerner College of Medicine, Case Western Reserve University; 6Department of Immunology, 7Animal Imaging Core, Lerner Research Institute, Cleveland Clinic; 8Case Comprehensive Cancer Center; 9Center of Visual Research, 10Case Center of Imaging Research, University Hospitals Case Medical Center, Cleveland, Ohio; 11Division of Hematology/Oncology, Department of Medicine, Columbia University, New York, New York Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital-Columbia University Medical Center, New York, New York, USA Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA. for the COVID-19 and Cancer Consortium (CCC19) Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA 5Department of Oncology, Montefiore/Albert Einstein Cancer Center, Bronx, New York. Department of Oncology, Albert Einstein College of Medicine, Bronx, NY, USA Department of Hematology/Oncology Columbia University Medical Center New York NY Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY 10461, USA Aditi P. Singh, Haiying Cheng, Xiaoling Guo, and Balazs Halmos, Montefiore Medical Center, Bronx, NY; and Benjamin Levy, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital, Washington, DC. Division of Hematology and Oncology, and Division of Hematology and Oncology, Columbia University Medical Center, New York, New York; and Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA Department of Medicine, Columbia University–College of Physicians and Surgeons, New York, New York, USA for the COVID-19 and Cancer Consortium Department of Oncology, Montefiore/Albert Einstein Cancer Center, Bronx, NY, USA Department of Medicine, New York Presbyterian Hospital - Columbia University Medical Center, Columbia College of Physicians and Surgeons, USA. |
Incoming Links
Showing number of triples: 1 to 225 of 225.